Cargando…
Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience
BACKGROUND: Adult medulloblastoma (MB) is rare, and management guidelines are largely based on pediatric clinical trials and retrospective series. Limited data exist with respect to clinical characteristics, prognostic factors, and outcomes based on first-line treatments. METHODS: Two hundred adults...
Autores principales: | Majd, Nazanin K, Mastall, Maximilan, Lin, Heather, Dibaj, Seyede Shiva, Hess, Kenneth R, Yuan, Ying, Garcia, Manuela Martin-Bejarano, Fuller, Gregory N, Alfaro, Kristin D, Gule-Monroe, Maria K, Huse, Jason T, Khatua, Soumen, Rao, Ganesh, Sandberg, David I, Wefel, Jeffrey S, Yeboa, Debra N, Paulino, Arnold C, McGovern, Susan L, Zaky, Wafik, Mahajan, Anita, Suki, Dima, Weathers, Shiao-Pei, Harriso, Rebecca A, De Groo, John F, Puduvalli, Vinay K, Penas-Prado, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350154/ https://www.ncbi.nlm.nih.gov/pubmed/34377987 http://dx.doi.org/10.1093/noajnl/vdab079 |
Ejemplares similares
-
Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience
por: Gregory, Timothy A, et al.
Publicado: (2023) -
EPEN-10. SPINAL MYXOPAPILLARY EPENDYMOMA AND METHYLATION-PROFILING: THE MD ANDERSON CANCER CENTER (MDACC) EXPERIENCE
por: Gupta, Sumit, et al.
Publicado: (2020) -
Dual inhibition of BRAF and mTOR in BRAF(V600E)-mutant pediatric, adolescent, and young adult brain tumors
por: Sen, Shiraj, et al.
Publicado: (2020) -
ETMR-04. EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES: THE MD ANDERSON CANCER CENTER EXPERIENCE
por: Gupta, Sumit, et al.
Publicado: (2020) -
IMG-15. PEDIATRIC GLIOBLASTOMAS CONTRAST ENHANCEMENT PATTERN IS PREDICTIVE OF SURVIVAL
por: Sadighi, Zsila, et al.
Publicado: (2020)